Got Lupus? Reduce Increased Risk of Cancer NOW-

Share Button

This comprehensive meta-analysis provides epidemiological evidence supporting the associations between Systemic Lupus Erythematosus and cancer risk.

If you have been living with lupus you already know that this little understood disease punishes its patients with an array of physical and mental problems. The last thing SLE patients need is to be diagnosed with cancer. According to the research linked and excerpted below, SLE increases the risk of 16 different types of cancer.

The solution must be 1) evidence-based, 2) non-toxic and 3) relatively inexpensive therapies shown to reduce your risk of cancer. These non-toxic therapies would be a combination of anti-angiogenic nutrition, anti-inflammatory supplementation, lifestyle therapies and more.

The PeopleBeatingCancer Coaching Program is comprised of 13 guides all shown to provide actionable therapies to reduce your risk of cancer. In short, these therapies are what I have been doing for the past 20 years to remain in complete remission from my own incurable blood cancer.

Have you been diagnosed with Systemic Lupus Erythematosus? Please scroll down the page, post a question or comment and I will reply to you ASAP.

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:


Systemic lupus erythematosus

Systemic lupus erythematosus (SLE), also known simply as lupus, is an autoimmune disease in which the body’s immune system mistakenly attacks healthy tissue in many parts of the body.[1] Symptoms vary between people and may be mild to severe.[1] Common symptoms include painful and swollen joints, fever, chest pain, hair loss, mouth ulcers, swollen lymph nodes, feeling tired, and a red rash which is most commonly on the face.[1] Often there are periods of illness, called flares, and periods of remission during which there are few symptoms.[1]..”

The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis

“Results- A total of 24 eligible studies were ultimately enrolled. Our results indicated that SLE was associated with increased risk of overall cancers, cancer risk in both genders, non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, leukemia, multiple myeloma, cervix, vagina/vulva, renal, bladder, esophagus, gastric, hepatobiliary, lung, oropharynx, larynx, non-melanoma skin, and thyroid cancers…

Conclusions-Our results shed light SLE being correlated with increased risk for 16 involved cancers and decreased risk for prostate cancer and cutaneous melanoma. This comprehensive meta-analysis provides epidemiological evidence supporting the associations between SLE and cancer risk…

The detailed characteristics of these 24 eligible studies are summarized in Table 1and (Additional file 2: Table S1). Specifically, a total of 24 human malignant neoplasms were systematically divided into six systemic groups (lymphatic and hematopoietic cancers, reproductive cancers, urinary cancers, digestive cancers, respiratory cancers, and others)…

Several potential mechanisms could account for cancer development in SLE patients. These patients, by virtue of their disease, have basic defects in immune cell function, resulting in immune dysregulation which might prevent aberrant cells from being removed and eventually contributing to increased cancer risk [49]. On the other hand, drugs for immunosuppressive therapy could also potentiate immune dysregulation and lead to further increased risks for developing cancer [50]…”

 

 

Leave a Comment:

1 comment
Add Your Reply